A comment on "The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle-aged and elderly population: a nationwide prospective cohort study".
作者信息
Wang Zhiying, Cao Baorui, Yang Meina, Han Jinxiang
机构信息
Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
NHC Key Laboratory of Biotechnology Drugs, Shandong Academy of Medical Sciences, Jinan, China.
出版信息
J Transl Med. 2025 Apr 11;23(1):428. doi: 10.1186/s12967-024-05969-z.
Abstract
摘要
相似文献
1
A comment on "The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle-aged and elderly population: a nationwide prospective cohort study".关于《肥胖代谢异质性及转变对中国中老年人群心血管疾病发病率的影响：一项全国性前瞻性队列研究》的评论
J Transl Med. 2025 Apr 11;23(1):428. doi: 10.1186/s12967-024-05969-z.
2
The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle-aged and elderly population: A nationwide prospective cohort study.肥胖及代谢变化的异质性对中国中老年人群心血管疾病发病率的影响：一项全国性前瞻性队列研究
Diabetes Obes Metab. 2025 Feb;27(2):501-510. doi: 10.1111/dom.16040. Epub 2024 Nov 4.
3
Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study.利用与肥胖和血脂相关的指标预测中国中老年人的高血压：来自中国健康与养老追踪调查的全国性队列研究。
BMC Cardiovasc Disord. 2023 Apr 20;23(1):201. doi: 10.1186/s12872-023-03232-9.
4
The effects of transitions in metabolic health and obesity status on incident cardiovascular disease: Insights from a general Chinese population.代谢健康和肥胖状态转变对心血管疾病发病的影响：来自一般中国人群的见解。
Eur J Prev Cardiol. 2021 Sep 20;28(11):1250-1258. doi: 10.1177/2047487320935550. Epub 2020 Jul 1.
5
Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study.老年人群中代谢功能障碍相关脂肪性肝病和晚期肝纤维化的发病率及超重/肥胖的影响：一项全国性队列研究
J Gastroenterol Hepatol. 2024 Dec;39(12):2845-2852. doi: 10.1111/jgh.16755. Epub 2024 Sep 29.
6
Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.代谢紊乱会增加中老年中国人患心血管疾病的风险。
Biomed Environ Sci. 2012 Feb;25(1):38-45. doi: 10.3967/0895-3988.2012.01.006.
7
Association of Metabolically Healthy Obesity and Risk of Cardiovascular Disease Among Adults in China: A Retrospective Cohort Study.中国成年人中代谢健康型肥胖与心血管疾病风险的关联：一项回顾性队列研究
Diabetes Metab Syndr Obes. 2023 Jan 19;16:151-159. doi: 10.2147/DMSO.S397243. eCollection 2023.
8
Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study.中国成年人中可改变的风险因素对糖尿病发病风险的影响存在年龄差异：一项全国性、基于人群的队列研究。
Lancet Healthy Longev. 2021 Oct;2(10):e618-e628. doi: 10.1016/S2666-7568(21)00177-X. Epub 2021 Sep 7.
9
Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies.代谢综合征风险分类与日本低肥胖患病率心血管疾病的发生率：10 项前瞻性队列研究的汇总分析。
J Am Heart Assoc. 2021 Dec 7;10(23):e020760. doi: 10.1161/JAHA.121.020760. Epub 2021 Nov 19.
10
Association between various insulin resistance indices and cardiovascular disease in middle-aged and elderly individuals: evidence from two prospectives nationwide cohort surveys.中年及老年人群中各种胰岛素抵抗指数与心血管疾病之间的关联：来自两项全国性前瞻性队列研究的证据
Front Endocrinol (Lausanne). 2024 Nov 22;15:1483468. doi: 10.3389/fendo.2024.1483468. eCollection 2024.
本文引用的文献
1
A biweekly DPP-4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.双周一次的二肽基肽酶-4抑制剂考福格列汀单药治疗中国糖耐量受损患者：一项2期、多中心、随机、双盲、安慰剂对照、平行组试验。
Diabetes Obes Metab. 2025 Feb;27(2):965-975. doi: 10.1111/dom.16096. Epub 2024 Dec 4.
2
Predictive ability of anthropometric indices for risk of developing metabolic syndrome: a cross-sectional study.人体测量指标预测代谢综合征发病风险的能力：一项横断面研究。
J Int Med Res. 2024 Nov;52(11):3000605241300017. doi: 10.1177/03000605241300017.
3
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohort.精神药物引起的体重增加与端粒长度：一项为期一年的纵向研究和一项大型基于人群的队列研究结果。
Transl Psychiatry. 2024 Nov 15;14(1):471. doi: 10.1038/s41398-024-03177-3.
4
The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle-aged and elderly population: A nationwide prospective cohort study.肥胖及代谢变化的异质性对中国中老年人群心血管疾病发病率的影响：一项全国性前瞻性队列研究
Diabetes Obes Metab. 2025 Feb;27(2):501-510. doi: 10.1111/dom.16040. Epub 2024 Nov 4.
5
The Prevalence of Metabolic Syndrome and Its Association With Waist Circumference in Middle-Aged Individuals From Urban Mumbai.孟买市区中年人群代谢综合征的患病率及其与腰围的关联
Cureus. 2024 Sep 18;16(9):e69669. doi: 10.7759/cureus.69669. eCollection 2024 Sep.
6
Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults.中国脑卒中的患病率、发病率和死亡率：一项基于全国 480687 名成年人的人口普查研究结果。
Circulation. 2017 Feb 21;135(8):759-771. doi: 10.1161/CIRCULATIONAHA.116.025250. Epub 2017 Jan 4.
Zotero 插件